Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pefloxacin in leprosy

R Bharti1

  • 1SMO UULC, Amritsar.

Indian Journal of Leprosy
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

This study found that adding pefloxacin to multidrug therapy (MDT) significantly improved leprosy treatment outcomes. Pefloxacin demonstrated rapid clinical improvement with no observed side effects in patients with leprosy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of laser bleaching, ultrasonic scaling and powered tooth brushing on surface roughness and bacterial adherence of class V composite restorations.

Journal of oral biology and craniofacial research·2023
Same author

S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.

Cancer gene therapy·2016
Same author

Tailor-Made Temperature-Sensitive Micelle for Targeted and On-Demand Release of Anticancer Drugs.

ACS applied materials & interfaces·2016
Same author

GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling.

Cell death & disease·2016
Same author

Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer.

Oncogene·2015
Same author

Chromoblastomycosis.

Indian journal of dermatology, venereology and leprology·2010
Same journal

Unilateral Cauliflower Ear due to Leprosy or Trauma - A Diagnostic Challenge.

Indian journal of leprosy·2018
Same journal

Pityriasis Rosea Localized to the Skin Patches of Leprosy. A Wolf's Isotopic Response?

Indian journal of leprosy·2018
Same journal

Cutaneous Sarcoidosis Misdiagnosed as Leprosy. Report of Two Cases and Review of Literature.

Indian journal of leprosy·2018
Same journal

Evaluation of New Antibacterial Drugs and their Combinations in a Murine Model to Identify Short Duration Alternative Chemotherapy for Leprosy.

Indian journal of leprosy·2018
Same journal

Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.

Indian journal of leprosy·2018
Same journal

Functioning and Disability in Leprosy.

Indian journal of leprosy·2018
See all related articles

Area of Science:

  • Pharmacology and Infectious Diseases
  • Antimicrobial Chemotherapy

Background:

  • Fluoroquinolones are a class of antimicrobials with broad-spectrum activity, including against mycobacteria, and limited toxicity.
  • Pefloxacin, a fluoroquinolone, has shown bactericidal activity against Mycobacterium leprae and clinical benefit in leprosy patients.

Purpose of the Study:

  • To evaluate the efficacy of adding pefloxacin to standard multidrug therapy (MDT) for previously untreated leprosy patients.
  • To compare clinical response in patients receiving MDT plus pefloxacin versus MDT alone.

Main Methods:

  • A pilot clinical trial comparing two groups of ten previously untreated leprosy patients (both paucibacillary and multibacillary).
  • One group received standard MDT plus pefloxacin; the control group received MDT alone.
  • Clinical response was quantified using a clinical scoring method.

Related Experiment Videos

Main Results:

  • The addition of pefloxacin to MDT resulted in significant and rapid clinical improvement compared to MDT alone.
  • No side effects were attributed to the addition of pefloxacin during the trial.

Conclusions:

  • Pefloxacin is a potentially valuable addition to standard MDT for treating leprosy.
  • Further research is warranted to confirm these findings in larger trials.